Document is current

Article History

Accepted: 31 July 2024

First Online: 19 August 2024

Change Date: 25 August 2024

Change Type: Update

Change Details: In this article the ESM file has been missed to be processed during the production process

Declarations

:

: S.C. is an AstraZeneca employee. A.G.D. and Y.I.M. work at Weber, a company that received fees from AstraZeneca, during the conduct of the study. R.L.L., S.L.T.C., and J.A.P.P. have participated as experts for Weber.

: S.C. and A.G.D. conceived and designed this study. All authors contributed to the acquisition of the data. A.G.D. and Y.I.M. contributed to the analysis of the data. All authors contributed to the interpretation of the data. A.G.D. and Y.I.M. contributed to the development of the drafts of this manuscript. S.C., R.L.L., S.L.T., and J.A.P.P. critically revised the manuscript. All authors approved the submitted version of the manuscript.

: This study was funded by AstraZeneca Farmacéutica Spain S.A.

: Not applicable.

: No patient data were collected; therefore, informed consent was not required.

: Not applicable.

: Model inputs are described in the manuscript, electronic supplementary material, and references. No further data and material are available.

: Data underlying the findings described in this manuscript may be obtained in accordance with AstraZeneca’s data-sharing policy, described at .

: The corresponding original Microsoft Excel model is confidential. All the data described in this manuscript and derived from the model can be obtained in accordance with AstraZeneca's data sharing policy, described at <u>.</u>